ConsumerAffairs12d
Statins don't affect kidney function, researchers find
Many older people develop chronic kidney disease and are also likely to be on cholesterol-lowering drugs known as statins.
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...
infectiousdiseaseadvisor.com3d
Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Medscape1d
Risk-Directed Management Key in Optimizing CKD Therapy
Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.
The American Journal of Managed Care4d
Weight Fluctuation Threatens Kidney Health in Type 1 Diabetes
Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...
The American Journal of Managed Care11d
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD
The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...